Screening of Fabry Disease of patients in renal replacement therapy in a population from Lazio (Italy).

European review for medical and pharmacological sciences(2023)

引用 0|浏览22
暂无评分
摘要
Considering the presence of an enzyme replacement therapy able to modify FD clinical history, it is essential to try to implement FD early diagnoses. However, the screening is too expensive to be extended on large scale, due to the low prevalence of the pathology. The screening should be performed on high-risk populations.
更多
查看译文
关键词
Fabry disease, Renal replacement therapy, Kidney transplantation, End stage renal disease, Lysosomal storage disease, Alpha-galactosidase, Lyso-Gb3
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要